Effects of Serum Triglycerides on Prostate Cancer and Breast Cancer Risk: A Meta-Analysis of Prospective Studies

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12), 2893–2917, 2010.
   PubMed Web of Science ®Google Scholar
• Shakeel S, Mahjabeen I, Kayani MA, and Faryal R: Association of SYK genetic variations with breast cancer pathogenesis. Asian Pac J Cancer Prev 14(5), 3309–3314, 2013.
   PubMedGoogle Scholar
• Parkin DM, Bray F, Ferlay J, and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55(2), 74–108, 2005.
   PubMed Web of Science ®Google Scholar
• Shakeel S, Mahjabeen I, Kayani MA, and Faryal R: Association of SYK genetic variations with breast cancer pathogenesis. Asian Pac J Cancer Prev 14, 3309–3314, 2013.
   PubMedGoogle Scholar
• Grundy SM and Denke MA: Dietary influences on serum lipids and lipoproteins. J Lipid Res 31, 1149–1172, 1990.
   PubMed Web of Science ®Google Scholar
• Drake BF, Keane TE, and Mosley CM: Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc 102(7), 241–249, 2006.
   PubMedGoogle Scholar
• Barnard RJ: Prostate cancer prevention by nutritional means to alleviate metabolic syndrome. Am J Clin Nutr 86(3), s889–s893, 2007.
   PubMed Web of Science ®Google Scholar
• Meyerhardt JA, Ma J, and Courneya KS: Energetics in colorectal and prostate cancer. J Clin Oncol 2010.
   Web of Science ®Google Scholar
• Mattson FH and Grundy SM: Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 26, 194–202, 1985.
   PubMed Web of Science ®Google Scholar
• Dreon DM, Vranizan KM, Krauss RM, Austin MA, and Wood PD: The effects of polyunsaturated fat vs monounsaturated fat on plasma lipoproteins. JAMA 263, 2462–2466, 1990.
   PubMed Web of Science ®Google Scholar
• Harris WS: Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30, 785–807, 1989.
   PubMed Web of Science ®Google Scholar
• Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, and Tryggvadottir L: Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6, 863–873, 1997.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, de Gonzalez A B, and Freedman ND: Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 29, 1592–1598, 2011.
   PubMed Web of Science ®Google Scholar
• Hoyer AP and Engholm G: Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control 3, 403–408, 1992.
   PubMed Web of Science ®Google Scholar
• Salem S, Mehrsai A, and Pourmand G: Prospective evaluation of serum triglyceride concentration and prostate cancer risk in a multicenter study. J Urology 78(3), s292, 2011.
   Google Scholar
• Cvetkovic Z, Cvetkovic B, Petrovic M, Debeljak-Martarcic J, Vucic V, et al.: Lipid profile as a prognostic factor in cancer patients. J BUON 14, 501–506, 2009.
   PubMed Web of Science ®Google Scholar
• Ulmer H, Borena W, and Rapp K: Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer 101(7), 1202–1206, 2009.
   PubMed Web of Science ®Google Scholar
• Van Hemelrijck M, Garmo H, and Holmberg L: Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose. Cancer 117(10), 2086–2095, 2011.
   PubMed Web of Science ®Google Scholar
• Melvin JC, Seth D, Holmberg L, Garmo H, Hammar N, et al.: Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiol Biomarkers Prev 21, 1381–1384, 2012.
   PubMed Web of Science ®Google Scholar
• Hayashi N, Matsushima M, Yamamoto T, Sasaki H, Takahashi H, and Egawa S: The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years. BJU Int 109(4), 515–519, 2012.
   PubMed Web of Science ®Google Scholar
• Wuermli L, Joerger M, and Henz S: Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate Cancer Prostatic Dis 8(4), 316–320, 2005.
   PubMed Web of Science ®Google Scholar
• Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, et al.: Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis 20, 41–48, 2010.
   PubMed Web of Science ®Google Scholar
• Lund HL, Wisloff TF, Holme I, and Nafstad P: Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 164(8), 769–774, 2006.
   PubMed Web of Science ®Google Scholar
• Grundmark B, Garmo H, Loda M, Busch C, Holmberg L, and Zethelius B: The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev 19(8), 2088–2096, 2010.
   PubMed Web of Science ®Google Scholar
• Haggstrom C, Stocks T, and Ulmert D: Prospective study on metabolic factors and risk of prostate cancer. Cancer 118(24), 6199–6206, 2012.
   PubMed Web of Science ®Google Scholar
• Inoue M, Noda M, and Kurahashi N: Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev 18(3), 240–247, 2009.
   PubMed Web of Science ®Google Scholar
• Kok DE, van Roermund JG, and Aben KK: Blood lipid levels and prostate cancer risk; a cohort study. Prostate Cancer Prostatic Dis 14(4), 340–345, 2011.
   PubMed Web of Science ®Google Scholar
• Martin RM, Vatten L, Gunnell D, Romundstad P, and Nilsen TI: Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control 20(7), 1181–1192, 2009.
   PubMed Web of Science ®Google Scholar
• Tande AJ, Platz EA, and Folsom AR: The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol 164(11), 1094–1102, 2006.
   PubMed Web of Science ®Google Scholar
• His M, Zelek L, and Deschasaux M: Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol 29(2), 119–132, 2014.
   PubMed Web of Science ®Google Scholar
• Bhindi B, Locke J, and Alibhai SM: Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort. Eur Urol 67(1), 64–70, 2015.
   PubMed Web of Science ®Google Scholar
• Gaard M, Tretli S, and Urdal P: Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women. Cancer Causes Control 5, 501–509, 1994.
   PubMed Web of Science ®Google Scholar
• Vatten LJ and Foss OP: Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res 50, 2341–2346, 1990.
   PubMed Web of Science ®Google Scholar
• Manjer J, Kaaks R, Riboli E, and Berglund G: Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur J Cancer Prev 10, 33–42, 2001.
   PubMed Web of Science ®Google Scholar
• Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, et al.: Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 19, 1737–1745, 2010.
   PubMed Web of Science ®Google Scholar
• Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 603–605, 2010.
   PubMed Web of Science ®Google Scholar
• Li C, Chen P, Hu P, Li M, Li X, et al.: Folate intake and MTHFR polymorphism C677T is not associated with ovarian cancer risk: evidence from the meta-analysis. Mol Biol Rep 40, 6547–6560, 2013.
   PubMed Web of Science ®Google Scholar
• Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539–1558, 2002.
   PubMed Web of Science ®Google Scholar
• Fleiss JL: The statistical basis of meta-analysis. Stat Methods Med Res 2, 121–145, 1993.
   PubMedGoogle Scholar
• Greenland S and Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135, 1301–1309, 1992.
   PubMed Web of Science ®Google Scholar
• Berlin JA, Longnecker MP, and Greenland S: Meta-analysis of epidemiologic dose-response data. Epidemiology 4, 218–228, 1993.
   PubMed Web of Science ®Google Scholar
• Aune D, Chan DS, Greenwood DC, Vieira AR, Rosenblatt DA, et al.: Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies. Ann Oncol 23, 1394–1402, 2012.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M, and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634, 1997.
   PubMed Web of Science ®Google Scholar
• Thompson SG and Higgins JPT: How should meta-regression analyses be undertaken and interpreted? Stat Med 21, 1559–1573, 2002.
   PubMed Web of Science ®Google Scholar
• Wang Y, Corr J, Thaler H, Tao Y, Fair W, and Heston W: Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 4, 1456–1462, 1995.
   Google Scholar
• Van Hemelrijck M, Garmo H, and Hammar N: The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study. Int J Cancer 130(9), 2118–2128, 2012.
   PubMed Web of Science ®Google Scholar
• Andreotti G, Chen J, and Gao Y T: Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China. Int J Cancer 122(10), 2322–2329, 2008.
   PubMed Web of Science ®Google Scholar
• Lindkvist B, Almquist M, Bjørge T, Stocks T, Borena W, et al.: Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project(Me-Can). Cancer Causes Control 24, 107–116, 2013.
   PubMed Web of Science ®Google Scholar